UK/US Market Expansion: What Life Sciences Firms Need to Know
A Strategic Overview for Entering and Scaling Operations Across the Atlantic
For UK-based Life Sciences and Pharma companies, the US remains a key market for international growth. But navigating expansion across the Atlantic brings significant financial, regulatory, and operational complexity.
In this 60-minute webinar, experts from MHA and the BTI network unpack the core challenges UK companies face when entering or scaling in the US market — from cross-border tax structuring and regulatory compliance to supply chain planning and talent strategy.
With practical insight and deep international expertise, this session highlights how MHA and the BTI network empower UK firms to expand with clarity, confidence, and full compliance — positioning them for long-term success in the world’s largest healthcare market.
Agenda
- Regulatory and compliance timelines for US entry
- Legal structures and operational readiness
- Cross-border tax and transfer pricing considerations
- Supply chain, tariffs, and resilience planning
- Talent strategy: in-house vs outsourced/partner-led models
Who Should Attend?
This session is designed for Life Sciences and Pharma firms expanding internationally, particularly across the UK/US corridor.
Speakers/Participants
-
Yogan A. Patel Head of Life Sciences & MedTechYogan qualified as a Chartered Accountant in 1983 and is Head of Life Sciences & MedTech here at MHA. Yogan is very much a key part of his clients' teams. As well as having an advisory role he acts as a facilitator, enabling clients to clearly see through the obstacles that face them and find the solutions, rather than the more traditional provision of straightforward business advice. To give you time to answer the big questions, your business must be running smoothly, but for it to run smoothly time must be given to important issues. Yogan works with clients through the planning process and helps to turn ideas into actions.
-
Darren Jones Compliance & Scaling Consultant
Darren is a risk management professional focused on the unique challenges of the life sciences industry by leveraging a 20-year career in audit, compliance and consulting where he supported a diverse global portfolio of clients spanning all stages of maturity.
-
Claus Anderson Legal & Operational Readiness
Claus specialises in all aspects of corporate and commercial work with a particular focus on mergers and acquisitions, shareholder agreements, joint ventures, licencing agreements and regulatory advice to companies and businesses in the Life Sciences and technology sector. Claus has also a wealth of experience in relation to inward investment, ie. overseas companies investing into the UK. Claus has for more than 15 years advised a number of businesses from Scandinavia, Central and Western Europe, Asia and the US about investing in the UK and what such businesses should look out for in that process.
-
Jonathan Dowding Tax & Structuring
Jonathan joined MHA in 2021 from EY’s International Tax Team, where he advised FTSE listed and private equity backed multi-national groups on a range of international and UK tax issues. Prior to this, Jonathan qualified as a CTA at a mid-tier accounting firm, where he provided tax advice and transaction support to large owner managed businesses and AIM quoted companies. Jonathan uses his international and UK tax experience to support his large corporate clients in collaboration with colleagues across the Baker Tilly International Network, in his role as Tax Director.
